NCT01418001: Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS) |
|
|
| Terminated | 1/2 | 5 | US | Pazopanib 400 mg QD - Gemcitabine and Docetaxel in Combination | Memorial Sloan Kettering Cancer Center, National Comprehensive Cancer Network, University of California, Los Angeles, Washington University School of Medicine, Northwestern University | Sarcoma, Leiomyosarcoma, Malignant Peripheral Nerve Sheath Tumor, Malignant Fibrous, Histiocytoma/Undifferentiated Pleomorphic Sarcoma | 11/15 | 11/15 | | |
